PepJunkie Home of the Peptonauts
More
HomeThe PulseAtlasDiscussHunter-GathererResearchProfileSearch

Research

Retinyl palmitate (Vitamin A palmitate) — living evidence map

The Atlas page holds the claims; this is how its evidence evolved.

Summary

Vitamin A deficiency affects about 190 million children under five in low- and middle-income countries; a Cochrane review of trials in about 1.2 million children found that synthetic vitamin A supplements reduced all-cause mortality by 12% (fixed-effect estimate). · pmid:28282701

Identity

PubChem CID 5280531: Retinol Palmitate, C36H60O2, 524.9 g/mol. · pubchem:5280531

CAS registry number 79-81-2. · pubchem:5280531

IUPAC name: [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate. · pubchem:5280531

Where the evidence actually sits

Established100%

Proportion of the 1 claim about Retinyl palmitate (Vitamin A palmitate) standing at each tier. Community volume is shown on the Consensus tab beside this and is never averaged into it.

Living evidence history

Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. (2017) · established20172017

1 resolved citation, oldest to newest, coloured by tier. Retractions and contradictions land here as they are recorded.

Structure

No structure representation on record. PepJunkie draws only what an authoritative record supplies; for a peptide that is the residue sequence, and none has been curated for Retinyl palmitate (Vitamin A palmitate) yet.

Dose evidence, rung by rung

A studied human dose exists on file. Open the rung: the dose is the paper's, in its context, never PepJunkie's.

  1. Approved-label dose · a resolved regulatory document names a labelled dose

    nothing resolved on this rung

  2. Studied human doses · resolved human studies at the established tier
    • Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. · pmid 28282701 · 2017
  3. Observational evidence · resolved human data at the emerging tier: thin, or contested

    nothing resolved on this rung

  4. Community-reported protocols · protocol propositions from distinct members, counted once per human

    nothing resolved on this rung

  5. Preclinical evidence · resolved animal, cell or mechanistic work

    nothing resolved on this rung

1 resolved citation, 0 unresolved (an unresolved citation lends nothing). Community volume is its own rung and is never averaged into the evidence rungs.